Belinda Hsi Dickie, MD, PhD

Surgical Director, Hemangioma and Vascular Malformation Program

Pediatric Surgeon, Colorectal Center

Academic Affiliations

Assistant Professor, UC Department of Pediatrics

Phone 513-636 3240


Colorectal surgery; vascular malformations; minimally invasive surgery; general pediatric surgery.

Visit the Dickie Lab.

Belinda Hsi Dickie, MD, PhD, is the surgical director of the Hemangioma and Vascular Malformations Center since July 2013. She is also the director of the Vascular Anomalies Fellowship. Dr. Dickie is an assistant professor with the Division of Pediatric General and Thoracic Surgery at Cincinnati Children's Hospital Medical Center within the UC Department of Pediatrics. She obtained her medical degree at the University of Toronto, and completed general surgery residency and an advanced minimally invasive surgery fellowship at the University of Alberta. She continued her training, completing fellowships in pediatric vascular malformations and pediatric colorectal surgery at Cincinnati Children’s Hospital Medical Center and in pediatric surgery at the University of Florida. She returned to Cincinnati Children’s in 2011.

Dr. Dickie has a special interest in the medical and surgical treatment of vascular malformations, and minimally invasive surgery. She has a lab in vascular biology which looks at the genetics and molecular pathways involved with lymphangiogenesis, and the genetics involved in the development of vascular malformations. The lab is looking at novel mutations in vascular malformations and the potential effects on lymphatic growth, and different treatment alternatives.

MD: University of Toronto, Toronto,Ontario, Canada 1998.

PhD: 2008.

Residency: General Surgery, University of Alberta, Edmonton, Alberta, Canada.

Fellowship: Advanced Minimally Invasive Surgery, University of Alberta, Edmonton, Alberta, Canada; Vascular anomalies, Cincinnati Children's, Cincinnati, OH; Pediatric Colorectal Surgery, Cincinnati Children's, Cincinnati, OH; Pediatric Surgery, University of Florida Gainesville, FL.

Certification: General Surgery, 2006; Pediatric Surgery, 2011.

View PubMed Publications

Dickie BH, Webb KM, Eradi B, Levitt MA. The problematic Soave cuff in Hirschsprung disease: Manifestations and treatment. J Pediatr Surg. 2014 Jan;49(1):77-81.

Knod JL, Garrison AP, Frischer JS, Dickie B. Foregut duplication cyst associated with esophageal atresia and tracheoesophageal fistula: a case report and literature review. J Pediatr Surg. 2013 May;48(5):E5-7.

de Blaauw I, Midrio P, Breech L, Bischoff A, Dickie B, Versteegh HP, Peña A, Levitt MA. Treatment of adults with unrecognized or inadequately repaired anorectal malformations: 17 cases of rectovestibular and rectoperineal fistulas. J Pediatr Adolesc Gynecol. 2013 Jun;26(3):156-60.

Levitt MA, Dickie B, Peña A. The Hirschsprungs patient who is soiling after what was considered a "successful" pull-through. Semin Pediatr Surg. 2012 Nov;21(4):344-53.

Murrell Z, Dickie B, Dasgupta R. Lung nodules in pediatric oncology patients: a prediction rule for when to biopsy. J Pediatr Surg. 2011 May;46(5):833-7.

Cuenca AG, Reddy SV, Dickie B, Kays DW, Islam S. The usefulness of the upper gastrointestinal series in the pediatric patient before anti-reflux procedure or gastrostomy tube placement. J Surg Res. 2011 Oct;170(2):247-52.

Levitt MA, Dickie B, Peña A. Evaluation and treatment of the patient with Hirschsprung disease who is not doing well after a pull-through procedure. Semin Pediatr Surg. 2010 May;19(2):146-53.

Dickie B, Dasgupta R, Nair R, Alonso MH, Ryckman FC, Tiao GM, Adams DM, Azizkhan RG. Spectrum of hepatic hemangiomas: management and outcome. J Pediatr Surg. 2009 Jan;44(1):125-33.

Kneteman NM, Weiner AJ, O'Connell J, Collett M, Gao T, Aukerman L, Kovelsky R, Ni ZJ, Zhu Q, Hashash A, Kline J, Hsi B, Schiller D, Douglas D, Tyrrell DL, Mercer DF. Anti-HCV therapies in chimeric scid-Alb/uPA mice parallel outcomes in human clinical application. Hepatology. 2006 Jun;43(6):1346-53.

Hao C, Song JH, Hsi B, Lewis J, Song DK, Petruk KC, Tyrrell DL, Kneteman NM. TRAIL inhibits tumor growth but is nontoxic to human hepatocytes in chimeric mice. Cancer Res. 2004 Dec 1;64(23):8502-6.